Monroe Terilyn J.

Chief People Officer sells 8.6K shares at $114.09 avg; -29.0% of holdings; stock +14.4% in 30 days

Monroe Terilyn J., Chief People Officer at Guardant Health, executed 3 separate sales on 2026-01-21 totaling 8,571 shares for $977,901.83, reducing her holdings by 29.0% from 29,561 to 20,990 shares at an average price of $114.09. The stock has since appreciated to $117.28 (+0.0% from 52-week high, +14.4% in 30 days), meaning the insider sold below the current price and missed recent gains. Guardant's fundamentals show strong revenue growth of +31.0% year-over-year to $265,196,000.00 in the latest quarter, but the company remains unprofitable with net income of $-92,725,000.00. Across the insider's cross-ticker trade history, prior sell positions have averaged a -4.0% 30-day return, and her recent activity at this ticker (5 prior trades in December and early January) has shown mixed outcomes with the most recent measurable 30-day returns near breakeven or slightly negative (-3.0%, -5.3%).

CPO Monroe Terilyn J. sells 10,031 shares at $112.08 avg for $1,124,279.49; holdings drop 32.3% to 21.0K at unprofitable GH.

Monroe Terilyn J., Chief People Officer, executed 3 separate sales totaling 10,031 shares for $1,124,279.49 at prices ranging from $111.75 to $113.44 on 2026-01-07, reducing her holdings from 31.0K to 21.0K shares (a 32.3% reduction). The sales occurred near the 52-week high of $112.33 and above the current price of $110.17. At the same-ticker level, her 5 prior sales at GH all dated 2025-12-01 show negative 30-day returns (-3.0% to -5.3%), suggesting a pattern of selling into strength; however, 90-day outcome data is not yet measurable for those prior trades. Guardant Health reported revenue of $265,196,000.00 in the latest quarter with net income of -$92,725,000.00, and the company remains unprofitable on a full-year basis despite +31.0% annual revenue growth. The transaction does not itself clarify strategic intent, but the substantial reduction in her equity position and recent repeat selling activity by this executive warrant investor attention in context of the company's ongoing unprofitability.

Monroe sold 55,167 shares for $5.8M at blended average $105.97 on Dec 1, reducing holdings by 72.5%.

Monroe Terilyn J., Chief People Officer, executed 7 separate sales totaling 55,167 shares for $5,846,163.49 on December 1, 2025, at prices ranging from $105.33 to $107.85, reducing her shareholding from 76,087 shares to 20,920 shares. This represents a substantial disposition of 72.5% of her prior holdings at prices near the current market level of $105.96. The company remains unprofitable with net income of $-92,725,000.00 on quarterly revenue of $265,196,000.00, though annual revenue growth stands at 31.0%, and the stock has appreciated 72.7% over 90 days from a 52-week low of $30.44. The scale of the reduction—from substantial holdings to materially lower post-transaction levels—merits investor attention in the context of ongoing operational losses despite strong top-line growth.